Your browser doesn't support javascript.
loading
Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma.
Casneuf, Tineke; Xu, Xu Steven; Adams, Homer C; Axel, Amy E; Chiu, Christopher; Khan, Imran; Ahmadi, Tahamtan; Yan, Xiaoyu; Lonial, Sagar; Plesner, Torben; Lokhorst, Henk M; van de Donk, Niels W C J; Clemens, Pamela L; Sasser, A Kate.
Afiliação
  • Casneuf T; Janssen Research & Development, Beerse, Belgium.
  • Xu XS; Janssen Research & Development, LLC, Raritan, NJ.
  • Adams HC; Janssen Research & Development, LLC, Spring House, PA.
  • Axel AE; Janssen Research & Development, LLC, Spring House, PA.
  • Chiu C; Janssen Research & Development, LLC, Spring House, PA.
  • Khan I; Janssen Research & Development, LLC, Raritan, NJ.
  • Ahmadi T; Janssen Research & Development, LLC, Spring House, PA.
  • Yan X; Janssen Research & Development, LLC, Raritan, NJ.
  • Lonial S; Winship Cancer Institute, Emory University School of Medicine, Atlanta, GA.
  • Plesner T; Vejle Hospital and University of Southern Denmark, Vejle, Denmark; and.
  • Lokhorst HM; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
  • van de Donk NWCJ; Department of Hematology, VU University Medical Center, Amsterdam, The Netherlands.
  • Clemens PL; Janssen Research & Development, LLC, Spring House, PA.
  • Sasser AK; Janssen Research & Development, LLC, Spring House, PA.
Blood Adv ; 1(23): 2105-2114, 2017 Oct 24.
Article em En | MEDLINE | ID: mdl-29296857
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Blood Adv Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Revista: Blood Adv Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Bélgica